Meet the Partners
Our partners play a crucial role in promoting the network and its activities. They are an essential part of making the Chanjo Hub mission achievable.
Avril Biopharma is an African-owned biotech company specialising in recombinant product development and business models for affordable, agriculture-based biomanufacturing. It offers rapid, safe, product development and manufacturing of next-generation vaccine, therapeutic, cosmeceutical and diagnostic products.
The Animal Research Institute (ARI) of the Council for Scientific and Industrial Research (CSIR) is a public institution formed in 1964 when the mandate was expanded to include areas of Animal Science other than Animal Health. The mandate of the CSIR-ARI is to develop and transfer technologies that promote livestock and poultry production in Ghana.
A leading independent technology innovation catalyst, bringing together academia, businesses, government, and investors, to translate ideas and research from innovation to commercialisation.
Accelerating innovation in RNA therapeutics:
• State-of-art-facilities including four GMP suites
• Plug and play end-to-end LNP and RNA vaccine manufacturing capabilities
• Able to manufacture up to a million doses of a vaccine in the event of a future health emergency
Tasa Pharma has established the first dedicated sterile manufacturing facility in East & Central Africa. The company has designed and built a world class GMP facility which aims to engage in the development, manufacture and distribution of high-quality sterile pharmaceutical products throughout the East and Central African region.
Liselo Labs is an African research and development company focused on a One Health centric management of disease in animals and humans, with capacity and experience in the development, clinical evaluation, and commercial-scale manufacture of immunotherapeutics and vaccines. Their collaborations with leading African and Global North governments, NGOs and research institutions bring about high-impact interventions relevant to the Global Health Agenda, with an Afrocentric focus.